Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: National Institute of Environmental Health Sciences Country of Publication: United States NLM ID: 0330411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-9924 (Electronic) Linking ISSN: 00916765 NLM ISO Abbreviation: Environ Health Perspect Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Research Triangle Park, N. C. National Institute of Environmental Health Sciences.
    • الموضوع:
    • نبذة مختصرة :
      Background: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) persist in the environment and are found in relatively high concentrations in animal livers. Studies in humans have reported inconsistent associations between PFOA and liver enzymes.
      Objectives: We examined the cross-sectional association between serum PFOA and PFOS concentrations with markers of liver function in adults.
      Methods: The C8 Health Project collected data on 69,030 persons; of these, a total of 47,092 adults were included in the present analysis. Linear regression models were fitted for natural log (ln)-transformed values of alanine transaminase (ALT), γ-glutamyltransferase (GGT), and direct bilirubin on PFOA, PFOS, and potential confounders. Logistic regression models were fitted comparing deciles of PFOA or PFOS in relation to high biomarker levels. A multilevel analysis comparing the evidence for association of PFOA with liver function at the individual level within water districts to that at the population level between water districts was also performed.
      Results: ln-PFOA and ln-PFOS were associated with ln-ALT in linear regression models [PFOA: coefficient, 0.022; 95% confidence interval (CI): 0.018, 0.025; PFOS: coefficient, 0.020; 95% CI: 0.014, 0.026] and with raised ALT in logistic regression models [with a steady increase in the odds ratio (OR) estimates across deciles of PFOA and PFOS; PFOA: OR = 1.10; 95% CI: 1.07, 1.13; PFOS: OR = 1.13; 95% CI: 1.07, 1.18]. There was less consistent evidence of an association of PFOA and GGT or bilirubin. The relationship with bilirubin appears to rise at low levels of PFOA and to fall again at higher levels.
      Conclusions: These results show a positive association between PFOA and PFOS concentrations and serum ALT level, a marker of hepatocellular damage.
    • References:
      Environ Pollut. 2011 Jan;159(1):169-174. (PMID: 20932617)
      PLoS Med. 2011 Oct;8(10):e1001117. (PMID: 22039356)
      J Occup Environ Med. 2009 Mar;51(3):364-72. (PMID: 19225424)
      Reprod Toxicol. 2009 Jun;27(3-4):266-277. (PMID: 19162173)
      Environ Sci Technol. 2006 Dec 15;40(24):7642-8. (PMID: 17256507)
      Environ Health Perspect. 2011 Dec;119(12):1760-5. (PMID: 21813367)
      J Occup Environ Med. 2006 Aug;48(8):759-70. (PMID: 16902368)
      PLoS One. 2009 Aug 27;4(8):e6796. (PMID: 19710929)
      Crit Rev Clin Lab Sci. 2001 Aug;38(4):263-355. (PMID: 11563810)
      Rev Environ Contam Toxicol. 2010;208:179-215. (PMID: 20811865)
      Gastroenterology. 2003 Jan;124(1):71-9. (PMID: 12512031)
      J Occup Environ Med. 2007 Oct;49(10):1086-96. (PMID: 18000414)
      N Engl J Med. 2004 Oct 7;351(15):1548-63. (PMID: 15470219)
      Am J Gastroenterol. 2003 May;98(5):960-7. (PMID: 12809815)
      Environ Sci Technol. 2004 Jul 1;38(13):3698-704. (PMID: 15296323)
      Diabetologia. 1985 Jul;28(7):412-9. (PMID: 3899825)
      Pediatrics. 2004 Jun;113(6):1776-82. (PMID: 15173506)
      Gastroenterology. 2005 Mar;128(3):627-35. (PMID: 15810122)
      Toxicol Sci. 2007 Oct;99(2):366-94. (PMID: 17519394)
      Toxicol Sci. 2008 Jan;101(1):132-9. (PMID: 17690133)
      Environ Health Perspect. 2009 Dec;117(12):1873-82. (PMID: 20049206)
      Environ Health Perspect. 2009 Jul;117(7):1083-8. (PMID: 19654917)
      Clin Chem Lab Med. 2002 Jul;40(7):718-24. (PMID: 12241021)
      Clin Chem Lab Med. 2002 Jul;40(7):734-8. (PMID: 12241023)
      Int Immunopharmacol. 2010 Nov;10(11):1420-7. (PMID: 20816993)
      Environ Int. 2011 Jan;37(1):86-92. (PMID: 20810169)
      Am J Clin Nutr. 2004 Apr;79(4):600-5. (PMID: 15051603)
      Toxicol Pathol. 2008 Jun;36(4):632-9. (PMID: 18467680)
      Int Arch Occup Environ Health. 2007 Nov;81(2):231-46. (PMID: 17605032)
      Am J Gastroenterol. 2010 Jun;105(6):1354-63. (PMID: 20010922)
      J Occup Environ Med. 2007 Aug;49(8):872-9. (PMID: 17693785)
      Environ Sci Technol. 2011 Oct 1;45(19):8037-45. (PMID: 21469664)
      Toxicology. 2011 Oct 9;288(1-3):8-17. (PMID: 21723365)
      PPAR Res. 2010;2010:. (PMID: 20885938)
    • الرقم المعرف:
      0 (Alkanesulfonic Acids)
      0 (Biomarkers)
      0 (Caprylates)
      0 (Environmental Pollutants)
      0 (Fluorocarbons)
      947VD76D3L (perfluorooctanoic acid)
      9H2MAI21CL (perfluorooctane sulfonic acid)
      EC 2.3.2.2 (gamma-Glutamyltransferase)
      EC 2.6.1.2 (Alanine Transaminase)
    • الموضوع:
      Date Created: 20120201 Date Completed: 20120822 Latest Revision: 20211021
    • الموضوع:
      20240628
    • الرقم المعرف:
      PMC3346788
    • الرقم المعرف:
      10.1289/ehp.1104436
    • الرقم المعرف:
      22289616